References
- Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev. 2008 May 22; 60(8):915–928.
- O’Hagan DT, Fox CB. New generation adjuvants–from empiricism to rational design. Vaccine. 2015 Jun 8; 33(Suppl 2):B14–B20.
- Saroja C, Lakshmi P, Bhaskaran S. Recent trends in vaccine delivery systems: a review. Int J Pharm Investig. 2011 Apr;1(2):64–74.
- Soema PC, Kompier R, Amorij JP, et al. Current and next generation influenza vaccines: formulation and production strategies. Eur J Pharm Biopharm. 2015 Aug;94:251–263.
- Suh H, Shin J, Kim YC. Microneedle patches for vaccine delivery. Clin Exp Vaccine Res. 2014 Jan;3(1):42–49.
- Beitelshees M, Li Y, Pfeifer BA. Enhancing vaccine effectiveness with delivery technology. Curr Opin Biotechnol. 2016 Mar;5(42):24–29.
- Wilhelm S, Tavares AJ, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016 May;1(5).
- Liu H, Irvine DJ. Guiding principles in the design of molecular bioconjugates for vaccine applications. Bioconjugate Chem. 2015 May 20; 26(5):791–801.
- Bloom DE, Madhavan G. Vaccines: from valuation to resource allocation. Vaccine. 2015 Jun 8; 33(Suppl 2):B52–B54.
- Barocchi MA, Black S, Rappuoli R. Multicriteria decision analysis and core values for enhancing vaccine-related decision-making. Sci Transl Med. 2016 Jun 29; 8(345):345ps14.
- Moyer TJ, Zmolek AC, Irvine DJ. Beyond antigens and adjuvants: formulating future vaccines. J Clin Invest. 2016 Mar 1;126(3):799–808.